Search
Now showing items 1-2 of 2
Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β.
(2022-10)
BACKGROUND: Interferon-β, a disease-modifying therapy (DMT) for MS, may be associated with less severe COVID-19 in people with MS. RESULTS: Among 5,568 patients (83.4% confirmed COVID-19), interferon-treated patients had ...
A single center observational study of the incidence, frequency and timing of critical care physiotherapy intervention during the COVID-19 pandemic.
(2022-08)
INTRODUCTION: The recent COVID-19 pandemic saw many patients admitted to an intensive care setting and requiring mechanical ventilation. The NHS increased their critical care beds which included expanding the amount of ...